EUCTR2008-002121-36-ATActive, not recruitingNot Applicable
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes MellitusWith Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on Insulin
Merck Sharp & Dohme GmbH0 sites550 target enrollmentStarted: June 30, 2008Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 550
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patient is 21 to 70 years old and currently on a stable dose of insulin for Type 2 Diabetes.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Patient has any history of Type 1 Diabetes; patient is on a weight loss program and is not in the maintenance phase, or patient is taking a weight loss medication (e.g., orlistat, sibutramine, rimonabant) within 8 weeks of Visit 1;patient has undergone surgery within 30 days prior to Visit 1 or has planned major surgery.
Investigators
Similar Trials
Active, not recruiting
Phase 1
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on InsuliTreatment of Type 2 DiabetesMedDRA version: 9.1 Level: LLT Classification code 10012601 Term: Diabetes mellitusEUCTR2008-002121-36-DKMerck & Co., Inc.950
Active, not recruiting
Phase 1
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin - Dose-Range Finding Study of MK-0941 in Patients with Type 2 Diabetes on InsuliEUCTR2008-002121-36-FIMSD Finland Oy550
Active, not recruiting
Phase 1
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on InsuliEUCTR2008-002121-36-FRaboratoires Merck Sharp & Dohme-Chibret550
Active, not recruiting
Phase 1
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose- Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on InsuliEUCTR2008-002121-36-BGMerck & Co. Inc.950
Active, not recruiting
Phase 1
A Phase IIb/III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Dose-Range Finding Clinical Trial of MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin. - NDType 2 Diabetes Mellitus With Inadequate Glycemic Control on InsulinMedDRA version: 9.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitusEUCTR2008-002121-36-ITMERCK & CO., INC.724